Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
7.49
+0.33 (4.61%)
Apr 30, 2026, 2:54 PM EDT - Market open
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $189.03 million as of April 30, 2026. Its market cap has increased by 158.88% in one year.
Market Cap
189.03M
Enterprise Value
147.88M
1-Year Change
158.88%
Ranking
Category
Stock Price
$7.49
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $189.03M, an increase of 184.30%. That is a compound annual growth rate of 24.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 180.63M | 45.66% |
| Dec 31, 2025 | 124.01M | 50.43% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | 66.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 191.32M |
| Humacyte | 188.16M |
| Canton Strategic Holdings | 186.97M |
| Korro Bio | 184.61M |
| Precision BioSciences | 183.20M |
| Tonix Pharmaceuticals Holding | 180.55M |
| Cartesian Therapeutics | 180.26M |
| Acumen Pharmaceuticals | 177.64M |